Arkstone Launches AI Platform to Help Clinicians Prescribe Antibiotics

The platform aims to cut down on overprescribing antibiotics, which is a key driver of antimicrobial resistance.

Nov. 4, 2026

Key Highlights

Arkstone has launched Arkstone Next, an AI platform for infectious disease guidance at the point of care.
The platform includes ARKIE, a clinician portal, an antimicrobial stewardship program, and guidance integrated into EHRs.
Arkstone says its models are trained, evaluated, and governed by infectious disease experts.
The platform is designed to support facilities without an infectious disease specialist on staff.
The launch comes amid concerns about unnecessary antibiotic use, which the CDC estimates accounts for at least 28% of outpatient prescriptions.

Arkstone has announced the launch of Arkstone Next, an AI platform that provides infectious disease guidance at the point of care. PR Newswire has the news.

The press release cites the CDC's Antimicrobial Resistance report, which HPN recently reported on. Overprescribing is a key driver of antibiotic resistance, and the agency estimates that at least 28% of outpatient antibiotic prescriptions are unnecessary.

Arkstone Next builds on OneChoice, which is the company's clinical decision support technology. The company's models are trained, valued, and governed by infectious disease experts. The new platform includes ARKIE, an AI assistant that helps clinicians work through infectious disease questions and interpret diagnostic results in moments; a portal that brings the guidance and reports into clinicians' daily workflow; an antimicrobial stewardship program; and guidance built into the EHR.

The platform will especially help facilities where no infectious disease specialist is present or on staff. It aims to help clinicians choose the right drug, dose, and duration.